THE COST OF STAGE IV MELANOMA WITH BRAF V600 MUTATIONS IN GREECE

被引：0
|
作者：
Carayanni, V [1 ]
Gogas, H. [2 ]
Bafaloukos, D. [3 ]
Boukovinas, I [4 ]
Latsou, D. [5 ]
Stamuli, E. [5 ]
Hatzikou, M. [5 ]
机构：
[1] Univ Western Attica, Alimos, Greece
[2] Natl & Kapodistrian Univ Athens, Athens, Greece
[3] Metropolitan Hosp, Athens, Greece
[4] Bioclin Oncol Unit Thessaloniki, Thessaloniki, Greece
[5] Pharmecons Easy Access, Varkiza, Greece
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN222
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [31] Therapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma
    Haugh, Alexandra
    Daud, Adil I.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (03) : 407 - 419
  • [32] Therapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma
    Alexandra Haugh
    Adil I. Daud
    American Journal of Clinical Dermatology, 2024, 25 : 407 - 419
  • [33] BRAF V600 Mutation Profile of Metastatic Melanoma in the Thrace Region of Turkey
    Can, Nuray
    Tastekin, Ebru
    Deniz Yalta, Tulin
    Sut, Necdet
    Korkmaz, Selma
    Usta, Ufuk
    Oz Puyan, Fulya
    Genc, Ezgi
    Cezik, Mert
    Binboga Tutug, Busem
    Kostek, Osman
    Tozkir, Hilmi
    TURKISH JOURNAL OF PATHOLOGY, 2018, 34 (02) : 134 - 142
  • [34] BRAF V600 mutational status in melanoma correlates with morphology in cytology specimens
    Lee, Paul J.
    Dennis, Katie
    Madan, Rashna
    Fan, Fang
    LABORATORY INVESTIGATION, 2018, 98 : 156 - 156
  • [35] Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF V600 Mutation
    Dhillon, Sohita
    TARGETED ONCOLOGY, 2016, 11 (03) : 417 - 428
  • [36] COST ANALYSIS MODEL BETWEEN THE COBAS BRAF TEST AND SANGER SEQUENCING WHEN TREATING MALIGNANT MELANOMA BASED ON THE PRESENCE OF V600 MUTATIONS
    Poulios, N.
    Pinto, L.
    Carlton, R.
    Bramley, T.
    Tierney, R.
    Palma, J. F.
    VALUE IN HEALTH, 2013, 16 (03) : A134 - A134
  • [37] BRAF V600 mutational status in melanoma correlates with morphology in cytology specimens
    Lee, Paul J.
    Dennis, Katie
    Madan, Rashna
    Fan, Fang
    MODERN PATHOLOGY, 2018, 31 : 156 - 156
  • [38] Advances in Treatment for Patients Unresectable or Metastatic BRAF V600 Mutated Melanoma
    Ying, A. C. H.
    HONG KONG JOURNAL OF RADIOLOGY, 2013, 16 (04): : S34 - S38
  • [39] BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay
    Tatsuno, Michiko
    Shioda, Yoko
    Iwafuchi, Hideto
    Yamazaki, Shigeki
    Iijima, Kenta
    Takahashi, Chiaki
    Ono, Hiromi
    Uchida, Kiyono
    Okamura, Osamu
    Matubayashi, Mamoru
    Okuyama, Torayuki
    Matsumoto, Kimikazu
    Yoshioka, Takako
    Nakazawa, Atsuko
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [40] COST OF 1ST LINE TREATMENT FAILURE IN BRAF V600 MUTATED METASTATIC MELANOMA IN FRANCE
    Cozzone, D.
    Dreno, B.
    Lebbe, C.
    Pinguet, J.
    Tehard, B.
    VALUE IN HEALTH, 2016, 19 (07) : A720 - A721
12345